IL10 and inflammatory bowel disease: Third, despite the lack of clinical evidence directly linking IL-10 signaling, goblet cells, and VEO-IBD, data from experimental models support this idea, and further investigation needs to be conducted to better understand how these factors play a role in the initiation of the disease.